US FDA Approves FoundationOne®CDx and FoundationOne®Liquid CDx as Companion Diagnostics for TALZENNA® (talazoparib) in Combination with XTANDI® (enzalutamide) to Ident…

Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced that it has received approvals from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx ...
The Mirror

Prostate cancer screening through a blood test 'could reduce deaths'

Screening men for prostate cancer through a blood test is likely to cut deaths from the condition, a new review has discovered.
The Guardian

Prostate cancer screening can save lives but ‘absolute benefit is small’, study says

Although blood test reduces deaths by two for every 1,000 men screened, many could face unnecessary treatment Screening for ...
Business Wire

Foundation Medicine Announces Expanded Participation in National Cancer Institute’s ComboMATCH Platform Trials Through Inclusion of Its High-Quality Blood-Based Biomarker ...

BOSTON--(BUSINESS WIRE)--Foundation Medicine, Inc., a global, patient-focused precision medicine company, today announced its ...
dw

Prostate cancer: A new at-home saliva test beats blood test

Scientists writing in the New England Journal of Medicine said a genetic test using saliva is more accurate than a PSA blood test ...